Training in Cancer Pharmacology
Training in Cancer Pharmacology
批准号:
7681012
负责人:
LEROY F LIU
金额:
$12.94万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-29 至 2011-08-31
中文摘要
描述(由申请人提供):罗伯特·伍德·约翰逊医学院药学系(RWJMS)与罗格斯大学欧内斯特·马里奥药学院(EMSOP, RU)和新泽西癌症研究所(CINJ)合作,正在申请资金支持癌症药理学博士后和博士前研究员的培训计划。该合作项目汇集了来自三个参与机构的教师,他们对癌症药理学有共同的兴趣。该项目的主要优势包括师资队伍的高质量、师资之间的现有研究合作以及学员在基础和应用癌症药理学方面的研究机会。此外,学员将能够:a)在位于新泽西州皮斯卡塔韦和新不伦瑞克省校园附近的制药行业实习,熟悉工业环境中临床前药物开发和癌症药理学的各个方面;b)亲眼观察癌症药理学在临床肿瘤学实践中的作用。培训补助金将是一个独特的机会,吸引有才华的候选人,并培养他们成为未来的癌症药理学研究科学家。博士预科学员将参加由RWJMS药理学部门管理的细胞和分子药理学研究生课程,包括课程学习和实验室研究。博士后研修生除了在一名教师的指导下进行癌症药理学的基础实验室研究外,还需要选修药学系开设的两门与癌症和癌症药理学相关的选修课程。该培训项目的教师导师来自三个机构,他们的研究兴趣广泛,包括细胞周期控制、肿瘤发生的基本机制、药物作用和耐药性的理解机制、癌症基因治疗和非侵入性体内成像,并对癌症药理学有共同的兴趣
英文摘要
DESCRIPTION (provided by applicant): The Pharmacology Department at the Robert Wood Johnson Medical School (RWJMS) in collaboration with the faculty at the Ernest Mario School of Pharmacy at Rutgers University (EMSOP, RU) and the Cancer Institute of New Jersey (CINJ), are requesting funds to support a training program in cancer pharmacology for postdoctoral and predoctoral fellows. The collaborative program brings together faculty from the three participating institutions with a common interest in cancer pharmacology. The major strengths of the program include the top quality of the faculty, existing research collaborations between the faculty and the opportunity for the trainees for research in both basic as well as applied cancer pharmacology. Additionally, the trainees will be able to: a) serve as interns in the pharmaceutical industry that are located in the immediate vicinity of the campus around Piscataway and New Brunswick, NJ to become familiar with various aspects of pre clinical drug development and cancer pharmacology in the industrial setting and b) observe first hand the role cancer pharmacology plays in clinical oncology practice. The training grant will be a unique opportunity to attract talented candidates and train them to become future research scientists in cancer pharmacology. The predoctoral trainees will be enrolled in the Cellular and Molecular Pharmacology Graduate Program administered by the Pharmacology Department at RWJMS that involves both course work and laboratory research. Postdoctoral trainees, in addition to basic laboratory research in cancer pharmacology with one of the faculty, will be required to take two of the elective courses related to cancer and cancer pharmacology offered in the Department of Pharmacology. The faculty mentors of this training program from the three institutions have a broad range of research interests that span cell cycle control, basic mechanisms of tumorigenesis, understanding mechanisms of drug action and resistance, cancer gene therapy and non-invasive in vivo imaging, with a shared interest in cancer pharmacology
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.yexcr.2008.07.028
发表时间:
2008-10-15
期刊:
Experimental cell research
影响因子:
3.7
作者:
[Lin SY, Yang J, Everett AD, Clevenger CV, Koneru M, Mishra PJ, Kamen B, Banerjee D, Glod J]
通讯作者:
Glod J
Training in Cancer Pharmacology
-
批准号:7128170
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:6894915
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7292666
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Training in Cancer Pharmacology
-
批准号:7498567
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2005
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8129544
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7526710
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7006957
-
项目类别:
-
资助金额:$28.02万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6782758
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8307026
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7669433
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:7869327
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:7194334
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of action of TOP2-directed anticancer drugs
-
批准号:6868144
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Mechanism of Action of TOP2-Directed Anticancer Drugs
-
批准号:8700947
-
项目类别:
-
资助金额:$6.58万
-
财政年份:2004
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6687804
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:6173399
-
项目类别:
-
资助金额:$22.6万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6621894
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
Topoisomerase I-directed Anticancer Drugs
-
批准号:6437280
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:2896423
-
项目类别:
-
资助金额:$21.94万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
PROTOBERBERINES AS DUAL POISONS OF TOPOISOMERASES
-
批准号:2592795
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1998
-
负责人:LEROY F LIU
-
依托单位:
海外基金